Deep Dives

Crucial Metrics to Monitor for Intuitive Surgical and a Valuation Analysis

Intuitive Surgical

A few months ago, we conducted an in-depth analysis of Intuitive Surgical (ISRG) and performed a preliminary valuation. In our most recent research, we dedicated time to a more comprehensive examination of Intuitive Surgical's growth prospects and financials. Our goal was to identify the essential factors that shape the company's performance and closely assess how its margins have evolved in recent years.

In this week's in-depth analysis, we will spotlight four pivotal factors: procedure growth, R&D investments, FCF margin, and international expansion. These key parameters are essential for gaining a deeper understanding of the company's growth potential and valuation.

West Pharmaceuticals (WST) - enabling pharmaceutical companies to get their products to their customers

Introduction West Pharmaceutical Services, Inc., founded in 1923 by Herman O. West, stands as a pioneering force in the global healthcare industry, with a rich history spanning nearly a century. Headquartered in Exton, Pennsylvania, West Pharma has evolved into a key player in providing innovative packaging components and delivery systems

Ascendis Pharma (ASND): Redefining Drug Delivery with TransCon

Introduction Ascendis Pharma is a biopharmaceutical company applying its TransCon technology to develop a pipeline of long-acting prodrug therapies with best-in-class profiles to address large markets with significant unmet medical needs. The company was founded in 2007 and is headquartered in Copenhagen, Denmark, with offices in the United States. The

Halozyme Therapeutics (HALO): Bets on Licensing Model to Drive Growth

Introduction Halozyme Therapeutics is a biotechnology company that was co-founded in 1998 by Dr. Gregory Frost and subsequently listed in 2014. Halozyme’s focus was on oncology therapies and drug delivery technologies based on its proprietary recombinant human hyaluronidase enzyme, rHuPH20, but following the failure of its oncology drug, the

Read next